MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/liv.70598

Медицинская библиотека · Liver international : official journal of the International Association for the Study of the Liver · 2026

Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated Cirrhosis.

Pompili Enrico, Iannone Giulia, Piano Salvatore, Toniutto Pierluigi, Lombardo Antonio, Gioia Stefania, Tonon Marta, Gagliardi Roberta, Carrello Daniele, Tedesco Greta, Di Marco Vito, Zaccherini Giacomo, Lani Lorenzo, Baldassarre Maurizio, Nardelli Silvia, Bitetto Davide, Calvaruso Vincenza, Angeli Paolo, Caraceni Paolo

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Long-term albumin (LTA) is effective for treating ascites in decompensated cirrhosis. This study aims to analyse the clinical courses of patients receiving LTA and provide a 3 month stratification to personalise management integrating LTA with other options.

METHODS

Patients receiving LTA included in the multicentre, retrospective, observational Real-ANSWER study were stratified into three categories according to the response of ascites after 3 months of treatment: 'responders' (grade 0-1 ascites), 'partial responders' (at least grade 2 ascites not receiving therapeutic paracentesis) and 'non-responders' (at least grade 2 ascites receiving therapeutic paracentesis). Clinical trajectories and outcomes of the different categories were compared.

RESULTS

Of the 252 patients included (median Child-Pugh 9, MELDNa 18), 36% were responders, 29% partial responders and 35% non-responders. Responders differed significantly from the other groups, with higher cumulative incidence of LTA discontinuation for clinical improvement (33%) and transplantation (26%), a lower 18 month mortality (13%) and minimal use of TIPS. Partial and non-responders showed similar trajectories with high mortality (35% and 42%) and low incidence of transplantation (12% and 11%). TIPS was performed predominantly among non-responders (15%). Both groups had a few patients (12% and 8%) able to stop LTA for clinical improvement frequently related to an effective etiologic treatment.

CONCLUSIONS

Using a 3 month stratification according to the ascites response of LTA, patients can be grouped into three categories with different clinical courses and outcomes. This may help to stratify prognosis and inform clinical discussions on the management of ascites by integrating LTA with other available options.

Для цитирования: Pompili Enrico, Iannone Giulia, Piano Salvatore, Toniutto Pierluigi, Lombardo Antonio, Gioia Stefania, Tonon Marta, Gagliardi Roberta, Carrello Daniele, Tedesco Greta, Di Marco Vito, Zaccherini Giacomo, Lani Lorenzo, Baldassarre Maurizio, Nardelli Silvia, Bitetto Davide, Calvaruso Vincenza, Angeli Paolo, Caraceni Paolo. Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated Cirrhosis.. Liver international : official journal of the International Association for the Study of the Liver. 2026. DOI: 10.1111/liv.70598.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.